Journalist: To reconcile the need for profits sufficient to support new drug research with the moral imperative to provide medicines to those who most need them but cannot afford them, some pharmaceutical companies feel justified in selling a drug in rich nations at one price and in poor nations at a much lower price. ███ ████ ████████ ██ ████████████ █ ██████ ████ █ ███ ███████ ██████ ███ █████ ████ █ ███████████ ██████ █████ ██████ ████ ██ ███ ███ ███ █████ ████ ███ ████ ██ ███ ██████ ████████ ██ ██ ███████ █████████ ███████
The journalist concludes that selling a drug at a higher price in wealthier countries and a lower price in poorer countries is unjustified. Why? Because there may be many middle-class people in poor countries who are more able to afford the drug than many poor people in rich countries.
The journalist concludes that charging more for drugs in rich countries and less in poor ones is unjustified, but his premises never tell us what would make such a practice unjustified. He assumes that companies aren’t justified in basing drug prices on a country’s overall wealth instead of the wealth of certain people or groups of people.
To help justify his reasoning, we need a rule or principle that satisfies his assumption and confirms that giving people special support or pricing based on their country’s income instead of their personal situation is unjustified.
Which one of the following ███████████ ██ ██████ ████ █████ ██ ███████ ███ ████████████ ██████████
People who are ███ ███████ ████ █████████████ ████ ██ ███████ ███████ ██████████ ██ █████ ████████ █████████████ ██████████
Wealthy institutions have ██ ██████████ ██ ██████ ██ █████ ████ ██ █████ █████████ ██ ██████ █████ █████████ ██ █████████ ███████████
Whether one deserves ███████ █████████████ ███████ ██ █████ █████ ██████ ████ ██ ███████████████ ██ ███ ███████ ██ █████ ███ ████████
The people in ███████ ███████ ██████ ███ ████ ██████ ██████ ██ ██████ ████ ████ ██ ███ ██████ ██ ██████ ████████
Unequal access to ██████ ████ ██ ████ ██████ ████ ██ ███████ ████████████ ██ ███████